Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case-control study

doi:10.21203/rs.3.rs-907801/v1

PDF

Research

Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case-control study

https://doi.org/10.21203/rs.3.rs-907801/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted 17 Sep, 2021

You are reading this latest preprint version

Objective: To explore the effects of establishing high dependency unit (HDU) on the prognosis, outcome, and expenditure of patients with severe community acquired pneumonia (SCAP).

Method: Data pertaining to 108 SCAP patients were retrieved from the respiratory intensive care unit (RICU) of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Of these, 87 qualified the study-selection criteria and were divided into HDU group (treated in HDU after discharge from RICU prior to transfer to normal unit) (n=40) and normal group (not treated in the HDU) (n=47). General condition of patients, APACHE II and SOFA scores, duration of mechanical ventilation, hospital infection, intensive care unit syndrome, length of stay, and expenditure were compared between the two groups.

Outcome: There was no significant between-group difference with respect to noninvasive ventilation time, oxygenation index, or APACHE II and SOFA scores at admission or discharge from RICU (P>0.05). Fourteen patients in the HDU group received invasive ventilation; the mean invasive ventilation time (176±160 h) was not significantly different from that in the normal group (206±179 h). The period of sequential noninvasive ventilation in the HDU group (135±82 h) was significantly shorter than that in the normal group (274±182 h, P<0.05). HDU group had shorter length of stay in hospital and RICU, and incurred lesser expenditure than patients in the normal group (P<0.05).

Conclusion: Patients in HDU group had almost the same therapeutic effect with shorter length of stay in hospital and RICU, and lesser expenditure.

Pulmonology

severe community acquired pneumonia (SCAP)

high dependency unit (HDU)

prognosis

length of stay

Globally, severe community-acquired pneumonia (SCAP) is a leading cause of sepsis in hospitalized patients and death from infectious diseases[1]. The mortality rate of SCAP patients who are admitted to intensive care unit (ICU) is approximately 30%[2]. Indeed, SCAP is associated with a high clinical burden besides the economic aspects. In a study by Dupuis et al, the median ICU stay and length of hospital stay of SCAP patients were 8 (4, 16) and 17 (10, 29) days, respectively, with the mean cost of €19,008 ± €17,218[3]. In the study by Çelikhisar et al, the length of stay in ICU of some of the SCAP patients was 19.05 ± 9.48 days[4]. Thus, improving the management of these patients is a key imperative.

Traditionally, SCAP patients are first admitted to the respiratory intensive care unit (RICU) and are shifted to normal units when their condition becomes stable; this is referred to as the RICU-normal unites (NU) pattern. However, prolonged treatment in RICU may cause delirium, secondary infection, and reduction in bed rotation rate[5]. In order to address these problems and simultaneously deliver enhanced respiratory care outside of the intensive care setting, a dedicated respiratory high-dependency unit (HDU), led by the same respiratory physicians and supported by the same specialist respiratory nursing and physiotherapy staff, was established beside the RICU. Respiratory support here is defined as noninvasive ventilation (NIV) and high-flow nasal oxygen (HFNO)[6]. SCAP patients are first admitted to RICU and then transferred to HDU, followed by their transfer to normal units when their condition improves. We called this as RICU-HDU-NU pattern, in which there is a transitional phase of treatment in the HDU. This pattern of care may reduce the length of stay (LOS) in the RICU, expenditure, and the incidence of ICU syndrome.

Some countries have developed HDUs after the breakout of COVID-19[7]. Nevertheless, most of these HDUs were used as a substitute for ICU rather than as a transitional unit. Even some were just used for speeding up the bed turnover and ease the burden of RICU beds[8]. In our hospital, we want to establish HDU to transform the pattern of care of SCAP patients resulting in medical and economic value.

In this study, we compared the RICU-NU pattern and RICU-HDU-NU pattern to explore the effects of establishing HDU on the prognosis, length of stay, and expenditure of SCAP patients.

Study design and patient recruitment

This was a single-center, retrospective, case-control study. All patients with SCAP who were admitted to the RICU of The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China between 1 March 2020 and 31 May 2021 were identified from the database. This database prospectively records the detailed clinical data including the history of present illness, past medical history, and personal history. Among these patients, some patients were transferred to HDU after extubation or when invasive mechanical ventilation was deemed unnecessary and transferred to normal units later upon stabilization of their condition. This group of patients was classified as the treatment group (referred to as the HDU group). Other patients were never shifted to HDU and could not be transferred to normal units after extubation until their condition stabilized with nasal tube oxygenation. This group of patients was classified as the control group (referred to as the normal group). The end-point of the observation was discharge of patients.

A total of 87 patients were included in the study, 40 in the HDU group and 47 in normal group.

Inclusion Criteria

Age > 18 years;
Qualified the diagnostic criteria of SCAP (2007 ATS/IDSA guidelines for the treatment of community-acquired pneumonia)[9]). Main criteria: a) requirement of invasive mechanical ventilation (IMV); b) development of shock which required use of vasoactive agents. Secondary criteria: a) respiratory rate >30 beats per minute; b) oxygenation index <250 mmHg; c) involvement of multiple lobes; d) altered consciousness; e) Blood Urea Nitrogen >20 mg/dL f) White blood cell count < 4×10⁹; g) platelet count <100×10⁹; h) core body temperature <36℃; i) fall in blood pressure requiring fluid resuscitation. Patients who qualify satisfy one main criteria or 3 secondary criteria can be diagnosed as SCAP.
Need for invasive mechanical ventilation and/or NIV and/or HFNO.
Admitted to RICU.
Length of hospital stay >3 days.

Exclusion Criteria

Patients who were discharged or transferred to another hospital during treatment.
Patients who did not require mechanical ventilation (invasive or noninvasive).
Patients who could not be extubated in RICU.

Laboratory Tests

Arterial blood gas analysis was performed for all patients at the time of admission to RICU, discharge from RICU, and discharge from the hospital. Blood routine, coagulogram, hepatic and renal function tests were performed at the time of admission to RICU and repeat tests were performed every 3 days. We scored APACHE II and SOFA scores at the time of admission to and discharge from the RICU.

Treatment

Patients in the RICU and HDU were treated by the same medical and nursing team, but with different nurse-to-patient ratio (1:2 vs 1:4, respectively). The treatment strategy was based on the 2007 ATS/IDSA guidelines for the treatment of community-acquired pneumonia. Briefly, the treatment included 3 main aspects: respiratory support, antibiotics, and general supportive measures.

Respiratory support was provided based on a standard protocol. Oxygen was administered via nasal tube to patients with oxygenation index >250 mmHg. NIV and HFNO therapy were provided to patients with oxygenation index between 100-250 mmHg. Endotracheal intubation and invasive mechanical ventilation were considered for patients with oxygenation index <100 mmHg. In most cases, the final decision was made by the medical team leader based on the specific circumstances. Moxifloxacin, Piperacillin/Tazobactam and Carbapenems were the most commonly used antibiotics for SCAP patients. Sometimes, antifungal drugs and glycopeptides antibiotics were also required.

In the HDU group, the endotracheal tube was removed from the intubated patients as soon as possible after they passed the spontaneous breath test aiming for target oxygen saturation (SaO₂) of 92%–96%[10] and transferred to HDU with the support of NIV or HFNO, if necessary. Other patients who did not require IMV from the very beginning were transferred to HDU 1-2 days after admission to the RICU supported by NIV or HFNO. Subsequently, when their condition stabilized, they were transferred to normal units.

In the normal group, the criteria for removal of the endotracheal tube in intubated patients was same as that in the HDU group. After extubation, they received NIV or HFNO, if necessary. Other patients in the normal group who did not require IMV from the beginning stayed in the RICU with the support of NIV or HFNO, until oxygen therapy via nasal tube could maintain their oxygenation level.

Statistical analyses

All analyses were conducted using SPSS 26.0. Normally-distributed continuous variables are expressed as mean ± standard deviation while non-normally continuous variables are expressed as median (interquartile range). Categorical variables are summarized as frequency (percentage). The t test or Mann-Whitney U test was used to analyze continuous variables, and the Fisher exact test or Pearson χ2 test was used for categorical variables.

During the study reference period, 115 patients were diagnosed with SCAP on admission. Among these, 3 patients were excluded as the length of hospital stay was less than 3 days and 2 patients were excluded as they were transferred to another hospital. Moreover, complete data were not available for 3 patients. Twenty patients could not get extubated in the RICU (Fig. 1). Finally, 87 patients (58 male, 66.7%) were included in this study (47 in the normal group and 40 in the HDU group). The mean age of patients was comparable in the two groups (HDU group: 66.4 ± 20.7 years; normal group: 65.2 ± 18.5 years; P > 0.05). Most patients had comorbid conditions. Hypertension, diabetes mellitus (DM) and coronary heart disease (CHD) were the most common comorbid conditions. Fourteen patients (35.0%) in the HDU group had one of the above diseases compared to 17 patients (36.2%) in the normal group. However, some patients had more than one comorbid conditions. Six patients in the HDU group had two comorbid conditions compared with 8 in the normal group. Four patients in the HDU group had three comorbid conditions compared with 2 in the normal group. In the HDU group, 2 patients had autoimmune disease (AID) and 4 had chronic obstructive pulmonary disease (COPD); the corresponding numbers in the normal group were 6 and 2, respectively. All of these comorbidities were reported to be stable in the chronic phase by the patients’ clinicians (Table 1).

Table 1

Comparison of the characteristics of patients in the HDU and normal groups
		HDU group n = 40	Normal group n = 47	t/X²/M-W	P
Age		66.4 ± 20.7	65.2 ± 18.5	0.276	0.783
Sex (n, %)	Male	25 (62.5)	33 (70.2)	0.578	0.447
Sex (n, %)	Female	15 (37.5)	14 (29.8)	0.578	0.447
Complication	One of Hypertension, DM and CHD	14 (35.0)	17 (36.2)	0.013	0.910
	Two of Hypertension, DM and CHD	6 (15.0)	8 (17.0)	0.065	0.798
	Hypertension, DM and CHD	4 (10.0)	2 (4.3)	1.111	0.407
	AID	2 (5.0)	6 (12.8)	1.561	0.279
	COPD	4 (10.0)	2 (4.3)	1.111	0.407
	Others	5 (12.5)	8 (17.0)	0.348	0.556
APACHE II score	At Admission to RICU	14.5(8.0,19.0)	15.0 (12.0, 24.3)	706.0	0.063
APACHE II score	At discharge from RICU	10.0 (6.3, 13.8)	11.0 (5.0, 17.8)	830.5	0.657
SOFA score	At admission to RICU	5.0 (3.0, 6.0)	5.0 (3.0, 8.0)	788.5	0.252
SOFA score	At discharge from RICU	2.0 (2.0, 4.0)	2.0 (1.0, 5.8)	836.0	0.689
Oxygenation index	At admission to RICU	208.4 ± 86.9	182.0 ± 81.0	1.460	0.148
	At discharge from RICU	256.7 ± 81.5	240.3 ± 121.5	0.737	0.463
	At discharge from hospital	247.3 ± 81.1	225.9 ± 120.5	0.936	0.352
Data presented as frequency (%), mean ± standard deviation or as median (interquartile range)

There was no significant between-group difference with respect to APACHE II and SOFA scores at the time of admission or discharge from RICU (P > 0.05). Also, there was no significant between-group difference with respect to oxygenation index at the time of admission or discharge from RICU, or even discharge from the hospital. The general condition of the patients in the two groups was comparable (Table 1).

Fourteen patients in the HDU group received IMV (mean invasive ventilation time: 176 ± 160 h) as against 24 in the normal group (mean invasive ventilation time: 206 ± 179 h). Most patients received sequential CPAP or HFNO after IMV. The sequential noninvasive ventilation period in the HDU group (135 ± 82 h) was significantly shorter less than that in the normal group (274 ± 182 h; P < 0.05) (Table 2).

Table 2

Comparison of ventilation period, ICU complications, and prognosis
	HDU group n = 40	Normal group n = 47	t/X²/M-W	P
Invasive ventilation (n, %)	14 (35.0)	24 (51.1)	2.267	0.132
Invasive ventilation period (h)	176 ± 160	206 ± 179	-0.524	0.603
Sequential noninvasive ventilation period (h)	135 ± 82	274 ± 182	-2.594	0.017
Noninvasive ventilation (n,%)	26 (65.0)	23 (48.9)	2.267	0.132
Noninvasive ventilation period (h)	125 (72, 187)	158 (82, 341)	220.5	0.334
ICU syndrome (n, %)	0	1 (2.1)	0.861	1.000
Hospital infection (including colonized bacteria and pathogenic bacteria) (n,%)	17 (42.5)	25 (53.2)	0.999	0.320
Returning ICU within 48 hours (n, %)	2 (5.0)	3 (6.4)	0.076	4.564
Mortality (n,%)	2 (5.0)	4 (8.5)	0.415	0.683
Length of stay in RICU	5.25 (3.5, 8.0)	8.5 (5.5, 15.0)	619.0	0.006
Length of stay in hospital	13.0 (8.5, 16.5)	25.5 (12.0, 34.0)	544.0	0.001
Expenditure (CNY)	55453 (38271, 90302)	99492 (54538, 201853)	533.0	0.001
Data presented as frequency (%), mean ± standard deviation or as median (interquartile range)
1 USD dollar = 6.455 CNY

Twenty-six patients in the HDU group received NIV (median ventilation period: 125 (72, 187) hours as against 23 in the normal group (median ventilation period: 158 (82, 341) hours (P > 0.05) (Table 2).

The number of deaths in the HDU and normal group were 2 (5.0%) and 4 (8.5%), respectively (P > 0.05). There was no significant between-group difference with respect to the incidence of ICU syndrome, nosocomial infection, or the rate of return to ICU within 48 hours (Table 2).

However, it is worth mentioning that the distribution of bacterial flora was significantly different between the two groups. The main organisms in the HDU group were Stenotrophomonas maltophilia and yeast compared with Staphylococcus aureus, Acinetobacter aumannii, and yeast in the normal group (Table 3, Fig. 2 and Fig. 3).

Table 3

Distribution of bacteria flora in the two groups
Bacteria (n, %)	HDU group (n = 17)	Normal group (n = 25)	P
Acinetobacter aumannii	3 (17.6)	4 (16.0)	> 0.05
Pseudomonas aeruginosa	1 (5.9)	3 (12.0)
Stenotrophomonas maltophilia	4 (23.5)	2 (8.0)
Klebsiella pneumoniae pneumoniae	1 (5.9)	2 (8.0)
Staphylococcus aureus	0	4 (16.0)
acinetobacter junii	0	1 (4.0)
Yeast	4 (23.5)	6 (24.0)
Corynebacterium striatum	1 (5.9)	0
Burkholderia vietnamiensis	1 (5.9)	0
Aspergillus fumigatus	1 (5.9)	0
Haemophilus influenzae	1 (5.9)	0

On the other aspects, the median length of stay in the hospital [13.0 (8.5, 16.5) days] and RICU [5.25 (3.5, 8.0) days] in the HDU group were shorter than those in the normal group [25.5 (12.0, 34.0) days and 8.5 (5.5, 15.0) days, respectively]. Moreover, the median expenditure incurred by patients in the HDU group [CNY 55453 (38271, 90302)] was significantly lesser than that in the normal group [CNY 99492 (54538, 201853) (P < 0.05)] (Table 2).

The incidence of SCAP has shown an increasing trend over the last decades and it is reported as one of the most common causes of sepsis in hospitalized patients[11]. SCAP is not only associated with high short-term and long-term mortality rates but also imposes a huge burden in clinical settings[12]. Hence, improving the management strategy for SCAP is a key imperative. SCAP usually necessitates ICU admission, mainly because of the need for mechanical ventilation or vasoactive agents. However, ICU admission can cause some complications, such as secondary infection, malnutrition, and ICU syndrome, which can lead to increased expenditure and prolonged LOS in ICU.

HDU, a setting outside of ICU but with critical care, provides a new pattern to manage SCAP patients. As a bridge between the ICU and the normal unit, HDU can allow provision of both close supervision and family company[13].

In our study, we compared the two management patterns of RICU-HDU-NU and RICU-NU in SCAP patients. We analyzed the clinical data of 87 SCAP patients including 40 in the HDU group and 47 in the normal group.

We found that patients in both two groups showed increase in oxygenation index and reduction in APACHE II and SOFA scores through treatment. There was no significant between-group difference with respect to oxygenation index, APACHE II score and SOFA score at the time of admission or discharge from RICU or the rate of return to ICU within 48 hours. This implied a comparable therapy effect in the two groups. Instead, patients in the HDU group had less sequential noninvasive ventilation period, shorter LOS in hospital and RICU, and lower expenditure. As expected, the RICU-HDU-NU pattern decreased the LOS and expenditure, but it did not decrease the therapy effect, which illustrates that this pattern can be developed for management of SCAP.

Hukins et al presented real-life data on the outcomes of HDU management of patients with respiratory failure at a tertiary care hospital in Australia. They found that use of NIV for treatment of hypoxaemic respiratory failure in HDU is effective in most patients[14].

The following reasons may explain the comparable outcomes in the two groups: 1) The same medical and nursing team was responsible for both groups to maintain the continuity in therapy, even though there were relatively lesser nurses in the HDU. With the stabilization of the patient’s condition and help of family, a nurse-patient ratio of 1:4 is acceptable. 2) With respect to nosocomial infection, Stenotrophomonas maltophilia and Yeast were the most commonly isolated organisms in the HDU group, which are not among the most common causes of hospital-acquired infection and less likely to be antibiotic-resistant. Nevertheless, Staphylococcus aureus and Acinetobacter aumannii, which are among the top 5 bacteria causing nosocomial infection according to 2021 CHINET data, were the main bacteria in the normal group, which are more likely to develop drug resistance. Thus, it would be easier to treat hospital infection in the HDU group. 3) Transferring the patient out of ICU as soon as possible decreases the LOS in ICU and minimizes the risk of secondary infection; in addition, the presence of family members helps decrease the risk of ICU syndrome. This may be related to the shorter period of sequential NIV and LOS in hospital. Decreased LOS is liable to reduce the expenditure.

In our study, although there was no significant difference with respect to the distribution of causative organisms of hospital-acquired infection, we found that most bacteria in HDU group seemed unfamiliar to normal ICU and may be less likely to be drug-resistant. A larger study in future may show significant difference in bacteria distribution. Moreover, inclusion of drug sensitivity test for all pathogens in future may help characterize the microbial profile in the two groups.

The mortality rate of patients with SCAP in the HDU and normal groups were 5% and 8.5%, respectively, which is lower than that in previous studies[15–16]. This was because we only analyzed the patients who had been transferred out of RICU, regardless of whether they were readmitted to RICU again or not. There were 20 patients who could not be extubated and died in RICU. Inclusion of these cases would increase the mortality rate to approximately 24.3%, which is closer to that reported in the study by Waldens et al[16].

Our study is of much clinical significance. We highlight a new strategy for management of SCAP which helped achieve good results. The RICU-HDU-NU pattern is worth developing for the treatment of SCAP patients. Moreover, establishing HDU can help ease the bed burden of RICU and nurses and improve the bed rotation rate, an assessment indicator in hospitals. Third, the company of family members in the HDU improves the satisfaction of patients and family members.

Owing to the increasing burden of severe pneumonia due to the COVID-19 pandemic, many countries have started to develop HDU[17–18]. However, the concept of HDU is not widely developed in China, and it is mostly designed for surgical patients[19]. The development of internal medicine HDU lags behind that of surgical HDU[20–21]. Our research may provide a new idea to develop internal medicine HDU in each specialty.

Some limitations of our study should be acknowledged. This was a retrospective, single-center study with a small sample size. Multicenter prospective studies are required to provide more definitive evidence of the benefits of HDU.

Ethics approval and consent to participate

The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University. Written informed consent was obtained from individual or guardian participants.

Consent for publication

Not applicable.

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Competing interests

The authors declare that they have no competing interests.

Funding

This study was supported in part by grants from Kuanren Elite Backbone Talents Special project of the Second Affiliated Hospital of Chongqing Medical University (KY2019G007).

Authors' contributions

Qin Yalan analyzed and interpreted the patient data and composed the manuscript. Tong Jin came up with the research idea and revised the manuscript. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Amalakuhan B, Echevarria KL, Restrepo MI. Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon. Expert Opin Pharmacother. 2017;18(11):1039–48.
Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021 Jan;217:107663.
Dupuis C, Sabra A, Patrier J, Chaize G, Saighi A, Féger C, Vainchtock A, Gaillat J, Timsit JF. Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs. Crit Care. 2021 Jan;10(1):24. 25(.
Çelikhisar H, Daşdemir Ilkhan G, Arabaci Ç. Prognostic factors in elderly patients admitted to the intensive care unit with community-acquired pneumonia. Aging Male. 2020 Dec;23(5):1425–31.
Lentz S, Roginski MA, Montrief T, et al. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. Am J Emerg Med. 2020 Oct;38(10):2194–202.
Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Curr Opin Pulm Med. 2021 May 1;27(3):210–215.
Aliberti S, Amati F, Pappalettera M, et al. COVID-19 multidisciplinary high dependency unit: the Milan model. Respir Res. 2020 Oct 9;21(1):260.
Tulloch A, How C, Brent M, Chapman R, Burns B, Pomery SM. Admission and discharge practices: High Dependency Unit audit outcome. Contemp Nurse. 2007 Feb;24(1):15–24.
Mandell LA, Wunderink RG, Anzueto A, Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar;44(1):27–72.
Windisch W, Weber-Carstens S, Kluge S, et al. Invasive and Non-Invasive Ventilation in Patients With COVID-19. Dtsch Arztebl Int. 2020 Aug 3;117(31–32):528–533.
Farahat FM, Bukhari OK, Basfar IA, et al. Clinical characteristics and outcomes of community-acquired pneumonia in western Saudi Arabia: A four-year retrospective analysis of medical records. J Infect Public Health. 2021 Jul;14(7):960–6.
Hayes BH, Haberling DL, Kennedy JL, et al. Burden of pneumonia-associated hospitalizations: United States, 2001–2014. Chest. 2018;153(2):427–37.
Amiruddin N, Prescott GJ, Coventry DA, et al. Evaluating service development in critical care: The impact of establishing a medical high dependency unit on intensive care unit workload, case mix, and mortality. J Intensive Care Soc. 2018 Aug;19(3):226–35.
Hukins C, Wong M, Murphy M, Upham J. Management of hypoxaemic respiratory failure in a Respiratory High-dependency Unit. Intern Med J. 2017 Jul;47(7):784–92.
Garnacho-Montero J, Barrero-Garcia I, Gomez-Prieto MG, et al. Severe community-acquired pneumonia: current management and future therapeutic alternatives. Exp Rev Anti-Infect Therapy. 2018;16(9):667–77.
Walden AP, Clarke GM, McKechnie S, et al. Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care. 2014 Apr;18(2):R58.
Helms J, Kremer S, Merdji H, et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. 2020 Aug;8(1):491. 24(.
Helms J, Kremer S, Merdji H, et al. Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care. 2020 Aug;8(1):491. 24(.
Dass D, Dhawan R, Maybin J,et al. Minimizing the need for high dependency unit support in adolescent idiopathic scoliosis surgery. Is enhanced recovery and the multidisciplinary team key? J Pediatr Orthop B. 2021 May 1;30(3):218–224.
Morton B, Banda NP, Nsomba E, et al. Establishment of a high-dependency unit in Malawi. BMJ Glob Health. 2020 Nov;5(11):e004041.
Hallifax RJ, Porter BM, Elder PJ, et al. Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience. BMJ Open Respir Res. 2020 Sep;7(1):e000678.
Wright CJ, Allan R. Progressing care in the Medical High Dependency Unit: unit configurations, staffing, standards, and daily routine. Acute Med. 2017;16(1):16–20.

PDF

Version 1

posted 17 Sep, 2021

You are reading this latest preprint version

Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case-control study

Status:

Version 1

Abstract

Figures

Introduction

Methods

Results

Discussion

Declarations

References

Status:

Version 1